Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

  • STATUS
    Recruiting
Updated on 19 February 2024

Summary

This study employs a multi-center approach to evaluate cutaneous vasculitis across several forms of idiopathic vasculitis. Patients with cutaneous manifestations of vasculitis will be evaluated by teams of primary vasculitis care providers and Dermatologists in order to facilitate optimal selection of patients and sampling of lesions. A punch skin biopsy at a site of active vasculitis will be the source of material for histopathologic and transcriptomic evaluation. The histopathology of cutaneous vasculitis will be characterized using a standardized, systematic approach. This approach includes a detailed description of abnormalities and extensive immunophenotyping of cell populations in the epidermal, dermal, and subcutaneous layers of skin. In addition to histologic description, skin biopsy material will be used a source of RNA for whole-genome gene expression profiling studies. Differential gene expression comparisons will be made across types of vasculitis. Disease-agnostic computational approaches will be used to discover novel ways to classify subgroups based upon global and specific patterns of gene expression. Additional samples will be collected (whole blood RNA, DNA) for potential secondary studies.

Details
Condition ['Cryoglobulinemic Vasculitis (CV)', 'Drug-induced Vasculitis', 'Eosinophilic Granulomatosis With Polyangiitis (EGPA)', 'IgA Vasculitis', 'Isolated Cutaneous Vasculitis', 'Granulomatosis With Polyangiitis (GPA)', 'Microscopic Polyangiitis (MPA)', 'Polyarteritis Nodosa (PAN)', 'Urticarial Vasculitis', 'Vasculitis']
Age 99years or below
Clinical Study IdentifierTBD
Last Modified on19 February 2024

Eligibility

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.